Legal Representation
Attorney
David M. Sullivan
USPTO Deadlines
Next Deadline
2067 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 18, 2025 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Mar 18, 2025 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
Feb 21, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 21, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 21, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 21, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 21, 2025 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
Feb 17, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 17, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 14, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 16, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 16, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Oct 16, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 16, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Apr 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Clinical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Laboratory testing of materials; Medical and scientific research information in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Providing a website featuring educational information in the field of clinical research
First Use Anywhere:
Mar 5, 2024
First Use in Commerce:
Mar 5, 2024
Class 044
Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels
First Use Anywhere:
Mar 5, 2024
First Use in Commerce:
Mar 5, 2024
Additional Information
Pseudo Mark
AUTO IMMUNE BRAIN PANEL
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PANEL"